Louisiana 2012 Regular Session

Louisiana Senate Bill SB348

Introduced
3/12/12  

Caption

Provides for the definitions of the Louisiana Pharmacy Practice Act. (8/1/12)

Impact

The impact of SB 348 on state laws is noteworthy as it seeks to streamline definitions that guide pharmacists and healthcare providers in the state. By redefining terms like 'administer', 'device', and 'distribute', the bill intends to ensure that professionals in the field have a clear understanding of their responsibilities and the legal implications of their actions. This is particularly important for compliance with both state and federal regulations, which can often be complex and change frequently.

Summary

Senate Bill 348, introduced by Senator Mills, makes amendments to the definitions within the Louisiana Pharmacy Practice Act. The bill focuses specifically on clarifying terms related to the administration of drugs, medical devices, and the distribution of pharmaceuticals. The amendments aim to enhance the precision of existing laws to better reflect current medical practices and legal requirements. This change is important for maintaining consistency in how these terms are applied across various healthcare settings in Louisiana.

Sentiment

General sentiment surrounding SB 348 appears to be positive among pharmacists and healthcare providers, as it supports clarity and precision in the practice of pharmacy. Stakeholders in the pharmacy sector recognize the necessity of having clear definitions to avoid legal ambiguities and ensure patient safety. However, there may be some concerns among legislators focused on broader regulatory impacts, who worry about the consequences of changes in legal definitions on practices already established.

Contention

While the bill does not seem to face significant opposition, potential points of contention could arise from stakeholders who advocate for more comprehensive reforms in the pharmacy sector rather than piecemeal amendments. Some might argue that while clarifying definitions is beneficial, it does not address larger issues related to pharmacy practice regulations or the distribution of pharmaceutical services in under-served areas.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.